2022 We Have Become a Shareholder of Neo Auvra. As a result of the search for new products, new production-sales-distribution relations/regions,…userJanuary 27, 2022
2022 Our manufacturing facility has received EU GMP approval from Germany. GEN has received European Union Good Manufacturing Practices (EU GMP) approval, which…userJanuary 5, 2022
2021 GEN is investing in a biotechnology start-up RS Research, developing novel drugs for cancer patients GEN İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş. (GEN), a leading…userDecember 15, 2021
202120212021202120212021 We Are Included In TURQUALITY® We are included in the Turquality program, the first-ever state-funded branding program…userSeptember 13, 2021
GEN and SULFATEQ Sign Definitive Collaboration Agreement SULFATEQ and GEN sign definitive collaboration agreement to develop a therapy for…userAugust 24, 2021
Partnership Between GEN and Albireo Pharma We are proud to announce that we have taken yet another important…userMay 10, 2021
We Added Russian Market To Our Partnership With Pharmaxis As GEN, we continue to deliver our Rare Solutions around the globe.…userApril 14, 2021
We Got Our Great Place To Work Certificate We got our Great Place To Work certificate. We value human life…userApril 13, 2021
2020 TUBITAK President Visits GEN’s Manufacturing Facility We are greatly pleased and honored to receive a visit to our…userJune 29, 2020
2020 Alnylam Pharmaceuticals and GEN Sign Distribution Agreement ZUG, Switzerland & ANKARA, Turkey--(BUSINESS WIRE)--Mar. 25, 2020-- Alnylam Pharmaceuticals, Inc. (Nasdaq:…userMay 25, 2020